Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Law

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Mayo Clinic Proceedings|August 13, 2003
Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levelsMartijn B Katan, Scott M Grundy, Peter Jones, et al.
Journal of Public Health Medicine|April 3, 2003
Contact tracing and population screening for tuberculosis--who should be assessed?Benjamin R Underwood, Veronica L C White, Tim Baker, et al.
Clinical Therapeutics|December 26, 2008
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reductionDavid S Wald, Malcolm Law, Sarah Mills, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Mayo Clinic Proceedings|August 13, 2003
Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levelsMartijn B Katan, Scott M Grundy, Peter Jones, et al.
Journal of Public Health Medicine|April 3, 2003
Contact tracing and population screening for tuberculosis--who should be assessed?Benjamin R Underwood, Veronica L C White, Tim Baker, et al.
Clinical Therapeutics|December 26, 2008
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reductionDavid S Wald, Malcolm Law, Sarah Mills, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
Pageof 4